|
End-of-day quote
Nasdaq
20/10/2026
|
5-day change | 1st Jan Change | ||
| 1.670 USD | +5.70% |
|
0.00% | -81.51% |
| 10-15 | EnGene Therapeutics Inc. - Special Call | |
| 09-21 | EnGene Therapeutics Inc.(NasdaqCM:ENGN) dropped from S&P Global BMI Index | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ENGN | End-of-day quote | |
CBOE
| ENGN | Real-time | |
|
Deutsche Boerse AG
| S0N0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.77 | 3.45 | 4.24 |
| Spread/Res. | -5.65% | -51.59% | -60.61% |
| Spread/Supp. | +15.97% | +15.97% | +11.33% |
| Support | 1.44 | 1.44 | 1.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ENGN Stock
- Charts enGene Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
